|
1
|
- The University of Alabama
|
|
2
|
- Health Insurance Portability and Accountability Act
- Protected Health Information (PHI)
- “Covered Entities” – health care providers such as hospitals, nursing
homes, clinics, and mental health centers.
- Places new requirements on use of PHI from covered entities for research
purposes.
- Privacy rule effective April 14, 2003.
|
|
3
|
- PHI includes any information that relates to past, present, or future
physical or mental health or condition of person; the provision of
health care to a person; or the past, present, or future payment for the
provision of health care to an individual.
- PHI excludes FERPA records and Employment records.
|
|
4
|
- HIPAA applies to UA’s “Health Care
- Components”: Capstone Medical
Center, Brewer-Porch, Student Health Center, Speech & Hearing
Clinic, Nursing Clinic.
- UA will have one common approach to HIPAA compliance, but each Health
Care Component will have their own set of policies.
|
|
5
|
- Any research that uses or discloses PHI obtained from any covered
entity, including a UA Health Care Component, must conform to HIPAA
research requirements.
- How the researcher uses or transmits the information does not define
whether or not the research must comply.
|
|
6
|
- Apply to:
- PHI from UA health care
components.
- PHI from any other covered entity.
- Do not apply to:
- PHI generated by the researcher
or other non-covered source.
- Research that does not use PHI.
|
|
7
|
- Wrongfully disclosing PHI: Fines up to $50,000 and up to 1 year in
prison.
- Obtaining PHI under false pretenses: Fines up to $100,000 and up to 5
years in prison.
- Failure to comply to HIPAA while conducting research that is considered
a commercial activity (paid for by a sponsor, or development of a device
or discovery that can be sold): Fines up to $250,000 and up to 10 years
in prison.
|
|
8
|
- Up to $100 per violation.
- Each name in a data set can be a violation.
- Not to exceed $25,000 per year.
- AND – civil monetary damages may be available to patients who win state
tort claims, such as breach of privacy.
|
|
9
|
- Research using PHI from covered entities must meet the standards of both
the Common Rule and HIPAA. (not instead of).
- Common Rule applies to federally regulated research on human subjects
and requires either an informed consent from participants or an IRB
waiver of informed consent.
|
|
10
|
- Statement by researcher describing the extent to which confidentiality
of records will be maintained.
- IRB must decide whether these confidentiality provisions are adequate.
- This requirement remains in place for all research subject to IRB.
|
|
11
|
- Receive valid authorization from the patient or subject in the study;
- Or, obtain a waiver from the UA’s IRB;
- Unless, the research falls under an exception (to be covered in more
slides).
|
|
12
|
- Specific description of information to be used or disclosed, specific to
the study;
- Name or identification of person or class of persons that will be
authorized to use or disclose the data;
- Description of each purpose of requested use and disclosure;
- Statement of the individual’s right to revoke authorization in writing,
including how to revoke and exceptions to this right; and . . .
|
|
13
|
- An expiration date or event, or a statement that there is no expiration
date;
- A statement describing whether or not the University is making
treatment, payment, enrollment, or eligibility for benefits contingent
on the authorization;
- A statement that information disclosed pursuant to the authorization may
be subject to further disclosure by the researcher and may no longer be
protected by the Privacy Rule; and
- The signature of the individual, and date.
|
|
14
|
- Cannot authorize the researcher to use the data for future unspecified
purposes.
- Must be written in plain language.
- MUST be obtained from every participant in a research study, unless the
IRB has provided a waiver.
- May be combined with informed consent form.
- If the PHI is to be used in more than one study, a separate signature is
required for each study.
|
|
15
|
- Proposed research could not practicably be conducted without the waiver,
and
- The research could not practicably be conducted without access to and
use of PHI.
- Use and disclosure of PHI involves no more than a minimal risk to
privacy.
|
|
16
|
- An adequate plan to protect the identifiers from improper use and
disclosure;
- An adequate plan to destroy the identifiers at the earliest opportunity
consistent with conduct of the research;
- Adequate written assurances that the PHI will not be reused or disclosed
to any other person or entity, except as required by law, or for
oversight of the project.
- HHS will issue Guidance
for IRBs
|
|
17
|
- 1. Research on records of decedents
- 2. Reviews preparatory to research
- 3. De-identified data
- 4. Use of Limited Data Sets
|
|
18
|
- If subject is dead, PHI from covered entities may be used or disclosed
solely for research purposes if the researcher represents PHI is
necessary for research.
- UA may request that the researcher provide documentation of the death of
the individual.
|
|
19
|
- Researcher must state that the use and disclosure is sought solely to
review PHI as necessary to prepare a research protocol or similar
purposes (recruitment);
- No PHI is to be removed from the covered entity in the course of the
review; and
- PHI being sought is necessary for the stated research purpose.
|
|
20
|
- If the researcher is also the subject’s treating physician, the
physician can recruit his/her patient for research without the patient’s
authorization.
|
|
21
|
- A statistician must conclude “the
risk is very small that the information could be used, alone or in
combination with other reasonably available information, by an
anticipated recipient to identify an individual who is the subject of
the information.”
- This is not expected to realistically be an available option.
|
|
22
|
- Name
- Addresses and zip codes
- Telephone Numbers
- Fax Numbers
- E-mail address
- Social Security Number
- Medical Record Numbers
- Full face photographic images
- URLs
- All elements of dates (except year)
- Medical record numbers
- Account Numbers
- Certificate/license numbers
- Vehicle identifiers
- Device identifiers
- Internet Protocols
- Biometric identifiers
- Any other identifying number or code.
|
|
23
|
- Can be used if the information is for research, public health, and
health care operations.
- Removes 16 of the identifiers, but allows researcher to keep dates
related to the individual (birth, death, date of admission or discharge)
and geographic info - zip code.
- Requires a Data Use Agreement that specifies permitted use of the data,
safeguards, and reporting if there is a breach.
|
|
24
|
- Establish permitted uses and disclosures of information,
- Establish who is permitted to use or receive the limited data set,
- Provide safeguards against and reporting of unauthorized disclosures,
control of subcontractors, and ensure the information does not become
identified and individuals are not contacted.
|
|
25
|
- Patients have a right to an accounting of disclosures made by a covered
entity unless:
- Patient signed an authorization, or
- Data was de-identified, or
- the Covered Entity only released a limited data set and recipient signed
a Data Use Agreement, or
- Covered Entity used/disclosed PHI for treatment, payment, or operations.
|
|
26
|
- If research is conducted with a waiver from the IRB, the Covered Entity
must provide an accounting to individuals in the study who request it
for up to 6 years.
- The accounting states who received the PHI, their address, and a brief
statement of the purpose of the disclosure.
- No accounting is required for disclosures prior to April 14, 2003.
|
|
27
|
- Must involve at least 50 records.
- Provide list of all protocols in which subject’s data may have been
used.
- Provide name and contact information of researcher.
- Participant must request an accounting.
- Covers a six year period.
- CE must help person contact researchers to whom it is likely the
person’s PHI was disclosed.
|
|
28
|
- Researchers at UA may use and disclose PHI from data sets created and
received before April 14, 2003 for research purposes if:
- The patient authorized use of PHI for research; or
- The patient signed an informed consent;
- Or the IRB waived informed consent.
|
|
29
|
- Will need to develop policies and procedures to guide the release of
PHI.
- Review research proposals.
- Review IRB documentation.
- Assess risk/benefit
- Negotiate a Data Use Agreement
- Prepare access to data to be shared
- Maintain record of PHI disclosures
|